Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2000
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000CA2374990A1 C-cam as an angiogenesis inhibitor
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374347A1 Screening method for peptides
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1057832A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same
12/06/2000EP1057480A2 Transdermal estrogen agonist-antagonist therapy
12/06/2000EP1057033A1 Treating cancer
12/06/2000EP1057032A2 Treating cancer
12/06/2000EP1057031A1 Treating cancer
12/06/2000EP1057030A2 Treating cancer
12/06/2000EP1057029A2 Treating cancer
12/06/2000EP1057028A1 Treating cancer
12/06/2000EP1057027A2 Treating cancer
12/06/2000EP1056869A2 Cell cycle related proteins
12/06/2000EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies
12/06/2000EP1056859A1 High affinity humanized anti-cea monoclonal antibodies
12/06/2000EP1056857A2 Transporter for saccharide-coupled medicaments
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056851A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72
12/06/2000EP1056849A1 Human smn-like protein
12/06/2000EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056834A2 Apoptotic cell-mediated antigen presentation to dendritic cells
12/06/2000EP1056780A1 Method of producing mouse and human endostatin
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/06/2000EP1056745A2 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
12/06/2000EP1056744A1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
12/06/2000EP1056736A1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position
12/06/2000EP1056732A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056725A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
12/06/2000EP1056720A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
12/06/2000EP1056716A1 Cyclohexanediole derivatives
12/06/2000EP1056704A1 Antitumor agents
12/06/2000EP1056472A2 Specific antibodies against mammary tumor-associated mucin, method for production and use
12/06/2000EP1056453A1 Use of epothilones for the treatment of cancer
12/06/2000EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
12/06/2000EP1056450A1 Farnesyl-protein transferase inhibitors
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000EP1056358A1 Use of d-tagatose as a prebiotic food component
12/06/2000EP0675733B1 Peptide-carbohydrate conjugates generating t-cell immunity
12/06/2000EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications
12/06/2000EP0591303B1 Methods and compositions for treating malaria and other diseases
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1275917A Potentiator for antibody against lymphoid tumor
12/06/2000CN1275915A Immunostimulatory and metastais inhibiting fermented vegetal material
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1275885A Precise efficary assay methods for active agents including chemotherapeutic agents
12/06/2000CN1275576A Human urine anti-tumor (antibacterial) peptide, its preparation and use
12/06/2000CN1275404A Anticancer medicine composition
12/06/2000CN1275377A Anticancer medicine composition
12/06/2000CN1059117C Katsutoxin pill for tumor and preparation process thereof
12/05/2000US6156798 Cardiovascular disorders, nervous system disorders, antiarthritic disorders and enzyme inhibitors
12/05/2000US6156791 Methods for treatment using procyanidin topoisomerase inhibitors
12/05/2000US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156755 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
12/05/2000US6156754 Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156739 Quinazolinone compounds
12/05/2000US6156736 Gene transcription and ionizing radiation: methods and compositions
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156321 Tissue factor methods and compositions for coagulation and tumor treatment
12/05/2000US6156320 Adminstering lactobacillus culture
12/05/2000US6156316 Forming human cytotoxic t-cell; contacting blood cells with peptide
12/05/2000US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000072008A2 Identification of novel mechanisms of drug resistance
11/30/2000WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000WO2000071740A1 High specificity hairpin antisense oligonucleotides
11/30/2000WO2000071736A1 Isoflavonoid methylation enzyme
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071708A2 Use of ef-ts for treating smooth muscle cell hyperplasia
11/30/2000WO2000071703A2 Inhibition of histone deacetylase
11/30/2000WO2000071693A2 Method for selecting improved vectors
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071563A2 Taccalonolide microtubule stabilizing agents
1 ... 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 ... 2211